Mannkind Corporation v. Miramar Professional Services et al, casdc:3:2022cv01686

Chemical preparations sold as a component of pharmaceuticals, that consist of diketopiperazine derivatives which are pH-driven self-assembling, self-disassembling microspheres, that are used to facilitate administration of pharmaceuticals;

Pharmaceutical preparations, namely, a drug delivery system comprising diketopiperazine derivative particles;

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF [CANCER AND] DIABETES;

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, cancer, endocrine diseases and disorders, metabolic diseases and disorders, and neoplastic diseases and disorders;

Medical devices, namely, devices for the administration of insulin, inhaler systems comprising inhalers and cartridges for administration of pharmaceuticals, and inhalers, and cartridges for use with inhalers, all provided empty; medical devices in the nature of inhalers used to measure patient inhalation effort and to train patients in personal inhaler use, medical devices in the nature of inhalers with features for measuring respiratory effort and facilitating the training of patients in use of inhalers, medical devices in the nature of inhalers with features for the measurement of respiratory patterns of patients, medical devices included as a component of inhaler systems for medical use, namely, patient monitors for monitoring and measuring respiration, apparatus for diagnosing or treating respiratory conditions, medical devices included as a component of inhaler systems for medical use, namely, devices used to indicate dosing of medication, medical devices included as a component of inhaler systems for medical use, namely, devices used to transmit and receive data regarding inhalation, respiration, or dosage;

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER AND DIABETES;